The interplay between suicidal experiences, psychotic experiences and interpersonal relationships: a qualitative study.

Interpersonal relationships Interviews Non-affective psychosis Qualitative methods Schizophrenia Suicidal behaviours Suicidal experiences Suicidal thoughts Suicidality

Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
24 Nov 2023
Historique:
received: 11 05 2023
accepted: 04 09 2023
medline: 27 11 2023
pubmed: 25 11 2023
entrez: 24 11 2023
Statut: epublish

Résumé

Suicidal thoughts, acts, plans and deaths are considerably more prevalent in people with non-affective psychosis, including schizophrenia, compared to the general population. Social isolation and interpersonal difficulties have been implicated in pathways which underpin suicidal experiences in people with severe mental health problems. However, the interactions between psychotic experiences, such as hallucinations and paranoia, suicidal experiences, and the presence, and indeed, absence of interpersonal relationships is poorly understood and insufficiently explored. The current study sought to contribute to this understanding. An inductive thematic analysis was conducted on transcripts of 22, individual, semi-structured interviews with adult participants who had both non-affective psychosis and recent suicidal experiences. A purposive sampling strategy was used. Trustworthiness of the analysis was assured with researcher triangulation. Participants relayed both positive and negative experiences of interpersonal relationships. A novel conceptual model is presented reflecting a highly complex interplay between a range of different suicidal experiences, psychosis, and aspects of interpersonal relationships. Three themes fed into this interplay, depicting dynamics between perceptions of i. not mattering and mattering, ii. becoming disconnected from other people, and iii. constraints versus freedom associated with sharing suicidal and psychotic experiences with others. This study revealed a detailed insight into ways in which interpersonal relationships are perceived to interact with psychotic and suicidal experiences in ways that can be both beneficial and challenging. This is important from scientific and clinical perspectives for understanding the complex pathways involved in suicidal experiences. ClinicalTrials.gov (NCT03114917), 14

Sections du résumé

BACKGROUND BACKGROUND
Suicidal thoughts, acts, plans and deaths are considerably more prevalent in people with non-affective psychosis, including schizophrenia, compared to the general population. Social isolation and interpersonal difficulties have been implicated in pathways which underpin suicidal experiences in people with severe mental health problems. However, the interactions between psychotic experiences, such as hallucinations and paranoia, suicidal experiences, and the presence, and indeed, absence of interpersonal relationships is poorly understood and insufficiently explored. The current study sought to contribute to this understanding.
METHODS METHODS
An inductive thematic analysis was conducted on transcripts of 22, individual, semi-structured interviews with adult participants who had both non-affective psychosis and recent suicidal experiences. A purposive sampling strategy was used. Trustworthiness of the analysis was assured with researcher triangulation.
RESULTS RESULTS
Participants relayed both positive and negative experiences of interpersonal relationships. A novel conceptual model is presented reflecting a highly complex interplay between a range of different suicidal experiences, psychosis, and aspects of interpersonal relationships. Three themes fed into this interplay, depicting dynamics between perceptions of i. not mattering and mattering, ii. becoming disconnected from other people, and iii. constraints versus freedom associated with sharing suicidal and psychotic experiences with others.
CONCLUSION CONCLUSIONS
This study revealed a detailed insight into ways in which interpersonal relationships are perceived to interact with psychotic and suicidal experiences in ways that can be both beneficial and challenging. This is important from scientific and clinical perspectives for understanding the complex pathways involved in suicidal experiences.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov (NCT03114917), 14

Identifiants

pubmed: 38001403
doi: 10.1186/s12888-023-05164-2
pii: 10.1186/s12888-023-05164-2
pmc: PMC10668454
doi:

Banques de données

ClinicalTrials.gov
['NCT03114917']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

873

Subventions

Organisme : Efficacy and Mechanism Evaluation Programme
ID : 13/161/25
Organisme : Efficacy and Mechanism Evaluation Programme
ID : 13/161/25
Organisme : Efficacy and Mechanism Evaluation Programme
ID : 13/161/25
Organisme : Efficacy and Mechanism Evaluation Programme
ID : 13/161/25
Organisme : Efficacy and Mechanism Evaluation Programme
ID : 13/161/25
Organisme : Efficacy and Mechanism Evaluation Programme
ID : 13/161/25
Organisme : Efficacy and Mechanism Evaluation Programme
ID : 13/161/25
Organisme : Efficacy and Mechanism Evaluation Programme
ID : 13/161/25
Organisme : Efficacy and Mechanism Evaluation Programme
ID : 13/161/25
Organisme : Efficacy and Mechanism Evaluation Programme
ID : 13/161/25
Organisme : Efficacy and Mechanism Evaluation Programme
ID : 13/161/25
Organisme : Efficacy and Mechanism Evaluation Programme
ID : 13/161/25
Organisme : Efficacy and Mechanism Evaluation Programme
ID : 13/161/25

Informations de copyright

© 2023. The Author(s).

Références

Psychol Psychother. 2020 Dec;93(4):777-809
pubmed: 31625283
Am J Psychiatry. 2004 Jan;161(1):53-8
pubmed: 14702250
Eur Psychiatry. 2022 Oct 11;65(1):e65
pubmed: 36216777
Front Psychiatry. 2017 Mar 08;8:35
pubmed: 28337154
Psychiatry Res. 2010 Jul 30;178(2):244-8
pubmed: 20472304
Front Psychol. 2020 Dec 17;11:563420
pubmed: 33391078
Acta Psychiatr Scand. 2015 Mar;131(3):162-73
pubmed: 25358861
Arch Suicide Res. 2021 Apr-Jun;25(2):315-339
pubmed: 31544686
Front Psychol. 2018 Nov 27;9:2139
pubmed: 30538647
Trials. 2021 May 25;22(1):366
pubmed: 34034792
Arch Gen Psychiatry. 2007 Oct;64(10):1123-31
pubmed: 17909124
Compr Psychiatry. 2014 Jan;55(1):104-12
pubmed: 23972619
Psychol Rev. 2010 Apr;117(2):575-600
pubmed: 20438238
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Apr 20;99:109835
pubmed: 31836507
J Affect Disord. 2012 Jan;136(1-2):54-62
pubmed: 21975135
Schizophr Res. 2014 Jul;156(2-3):204-10
pubmed: 24853059
Early Interv Psychiatry. 2021 Jun;15(3):497-504
pubmed: 32291972
BMJ Qual Saf. 2022 Jun;31(6):419-422
pubmed: 34607913
Psychol Sci Public Interest. 2014 Oct;15(2):37-70
pubmed: 26171956
Int J Environ Res Public Health. 2022 Mar 23;19(7):
pubmed: 35409502
World Psychiatry. 2014 Jun;13(2):153-60
pubmed: 24890068
Evid Based Ment Health. 2010 May;13(2):35-40
pubmed: 21856603
Lancet Psychiatry. 2014 Jun;1(1):73-85
pubmed: 26360404
J Affect Disord. 2019 Feb 15;245:653-667
pubmed: 30445391
JAMA Psychiatry. 2015 Mar;72(3):219-25
pubmed: 25715312
Health Expect. 2017 Jun;20(3):373-384
pubmed: 27124178
Philos Trans R Soc Lond B Biol Sci. 2018 Sep 5;373(1754):
pubmed: 30012735
Suicide Life Threat Behav. 2007 Feb;37(1):1-9
pubmed: 17397275
Lancet. 2022 May 14;399(10338):1903-1916
pubmed: 35512727
Psychol Bull. 2011 May;137(3):391-420
pubmed: 21443319
Int J Ment Health Addict. 2021;19(6):2443-2469
pubmed: 32837430
J Nerv Ment Dis. 2022 Jun 1;210(6):432-438
pubmed: 34966112
Behav Res Ther. 2010 Mar;48(3):179-86
pubmed: 19906364
Clin Psychol Rev. 2011 Jun;31(4):563-91
pubmed: 21276646
BMC Psychiatry. 2020 Jun 16;20(1):306
pubmed: 32546129
Crisis. 2009;30(1):13-9
pubmed: 19261563
Psychol Med. 2020 Apr;50(5):705-726
pubmed: 32063250
Suicide Life Threat Behav. 2003 Winter;33(4):443-7
pubmed: 14695058
Br J Psychiatry. 2020 Dec;217(6):717-724
pubmed: 32744207
Qual Health Res. 2019 Feb;29(3):315-327
pubmed: 30222044
PLoS Med. 2022 Dec 13;19(12):e1004139
pubmed: 36512523
Suicide Life Threat Behav. 2014 Aug;44(4):372-83
pubmed: 24527848
J Aging Health. 2019 Dec;31(10):1830-1849
pubmed: 30182793
J Affect Disord. 2013 Mar 5;145(3):356-62
pubmed: 23021191
J Nerv Ment Dis. 2016 Nov;204(11):840-844
pubmed: 26915014
Arch Suicide Res. 2010;14(3):236-47
pubmed: 20658377
Suicide Life Threat Behav. 2019 Aug;49(4):1006-1018
pubmed: 30091197
Psychother Res. 2020 Jan;30(1):124-136
pubmed: 30409079
Behav Res Ther. 2010 Sep;48(9):883-9
pubmed: 20538264
BJPsych Open. 2019 Sep 09;5(5):e79
pubmed: 31496458
Schizophr Res. 2016 Apr;172(1-3):195-200
pubmed: 26948502
Indian J Psychiatry. 2013 Jan;55(1):46-51
pubmed: 23439644
J Affect Disord. 2020 Feb 15;263:621-628
pubmed: 31744741
Schizophr Res. 2021 Feb;228:43-50
pubmed: 33434731
Psychotherapy (Chic). 2021 Dec;58(4):533-543
pubmed: 33734741
Psychiatry Res. 2020 Jun;288:112950
pubmed: 32361335
Schizophr Res. 2019 Jun;208:167-172
pubmed: 30940400
Int J Soc Psychiatry. 2022 Jun;68(4):898-907
pubmed: 33876666
Psychopathology. 2013;46(3):176-85
pubmed: 22906962
Psychol Psychother. 2003 Dec;76(Pt 4):369-83
pubmed: 14670187
Suicide Life Threat Behav. 2022 Oct;52(5):1037-1047
pubmed: 35815892
Schizophr Res. 2017 May;183:137-142
pubmed: 27916286
J Abnorm Psychol. 2009 Aug;118(3):634-646
pubmed: 19685959
Health Soc Work. 2001 Aug;26(3):188-95
pubmed: 11531195
J Ment Health. 2019 Dec;28(6):597-603
pubmed: 28635432
J Clin Psychol. 2009 Dec;65(12):1291-9
pubmed: 19827114
Psychiatry Res. 2018 Dec;270:13-19
pubmed: 30243127
Psychol Addict Behav. 2011 Mar;25(1):180-4
pubmed: 21142333
Psychol Med. 2004 Nov;34(8):1571-80
pubmed: 15724887
Psychiatry Res. 2017 Nov;257:309-314
pubmed: 28797954
BMC Med Res Methodol. 2018 Nov 21;18(1):148
pubmed: 30463515
BJPsych Open. 2022 Jun 03;8(4):e105
pubmed: 35656578
J Nerv Ment Dis. 2010 May;198(5):343-8
pubmed: 20458196
Public Health. 2017 Nov;152:157-171
pubmed: 28915435
J Affect Disord. 2022 Feb 1;298(Pt A):248-255
pubmed: 34728279
Psychol Bull. 2017 Dec;143(12):1313-1345
pubmed: 29072480

Auteurs

Patricia Gooding (P)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Coupland Building 1, Oxford Road, Manchester, M13 9PL, UK. patricia.a.gooding@manchester.ac.uk.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK. patricia.a.gooding@manchester.ac.uk.

Gillian Haddock (G)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Coupland Building 1, Oxford Road, Manchester, M13 9PL, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Kamelia Harris (K)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Coupland Building 1, Oxford Road, Manchester, M13 9PL, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Menita Asriah (M)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Coupland Building 1, Oxford Road, Manchester, M13 9PL, UK.

Yvonne Awenat (Y)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Coupland Building 1, Oxford Road, Manchester, M13 9PL, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Leanne Cook (L)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Coupland Building 1, Oxford Road, Manchester, M13 9PL, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Richard J Drake (RJ)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Coupland Building 1, Oxford Road, Manchester, M13 9PL, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Richard Emsley (R)

Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK.

Charlotte Huggett (C)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Coupland Building 1, Oxford Road, Manchester, M13 9PL, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Steven Jones (S)

Lancashire and South Cumbria, NHS Foundation Trust, Lancashire, UK.
Spectrum Centre for Mental Health Research, Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.

Fiona Lobban (F)

Lancashire and South Cumbria, NHS Foundation Trust, Lancashire, UK.
Spectrum Centre for Mental Health Research, Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.

Paul Marshall (P)

Lancashire and South Cumbria, NHS Foundation Trust, Lancashire, UK.
Spectrum Centre for Mental Health Research, Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.

Daniel Pratt (D)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Coupland Building 1, Oxford Road, Manchester, M13 9PL, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Sarah Peters (S)

Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Coupland Building 1, Oxford Road, Manchester, M13 9PL, UK.
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH